DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
about
The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapseNucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expressionThe dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowthThe schizophrenia susceptibility gene dysbindin controls synaptic homeostasisThe EARP Complex and Its Interactor EIPR-1 Are Required for Cargo Sorting to Dense-Core VesiclesThe ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in miceSnapin facilitates the synchronization of synaptic vesicle fusionHermansky-Pudlak protein complexes, AP-3 and BLOC-1, differentially regulate presynaptic composition in the striatum and hippocampusDysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formationRole of dysbindin in dopamine receptor trafficking and cortical GABA functionImpaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophreniaAnimal Models of Psychosis: Current State and Future Directions.Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and developmentBehavioral characterization of mice overexpressing human dysbindin-1.Animal models of schizophrenia.Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways.Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia.Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patientsDysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic modelsModeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsNeurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.Age-dependent regulation of synaptic connections by dopamine D2 receptors.Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiency.Components of the basal lamina and dystrophin-dystroglycan complex in the neurointermediate lobe of rat pituitary gland: different localizations of beta-dystroglycan, dystrobrevins, alpha1-syntrophin, and aquaporin-4.Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.An inhibitory effect of extracellular Ca2+ on Ca2+-dependent exocytosis.DISC1 in schizophrenia: genetic mouse models and human genomic imaging.Dysbindin-1C is required for the survival of hilar mossy cells and the maturation of adult newborn neurons in dentate gyrus.Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.Dysbindin-1 genotype effects on emotional working memoryMeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons.Muscarinic inhibition of nicotinic transmission in rat sympathetic neurons and adrenal chromaffin cells.The Schizophrenia-Related Protein Dysbindin-1A Is Degraded and Facilitates NF-Kappa B Activity in the NucleusImpaired long-term potentiation and long-term memory deficits in xCT-deficient sut mice.Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.Regulation of synaptic activity by snapin-mediated endolysosomal transport and sorting.Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.
P2860
Q24293250-877E5264-4A96-4A21-8B3F-56AA75AD3DA6Q24301877-7E6F39AD-8B08-43A5-B773-D610DE1275C5Q24338919-7B298C45-608E-4012-A5D8-847B267F57C2Q24632783-DCE4B924-65C6-412F-B56A-A2A840742E98Q27308807-C1D55DC1-72A4-44B2-A3FF-2B6D6358E5E2Q28288084-69FE4808-694A-4E9B-AF32-D837D06FDB9FQ28508747-EF5F5C06-A592-46D6-857B-43D661641322Q28513167-AE3681FA-E426-4950-BEBD-A02E93F7F2FBQ28572652-A8AB2509-539B-486A-9B7A-E081F727850CQ28593127-D327E347-BA0F-4186-BB31-6EF3F6651C0DQ28756538-572C3AD0-647C-47CD-A087-8A0BF2CD38EBQ30410153-E90D2D02-95C1-4B38-A490-A11CB52F2E62Q30414108-779DDDCA-0A32-4B40-98CD-6AB10BE6BC77Q30428226-88F80F1C-D44B-4948-A06B-E085D5BC1CD4Q30462828-035A72D4-35F6-4FAD-943A-D8EDB78E083DQ30465987-8D54D354-81B7-4807-AD7C-99E2955DF9CCQ30468313-63B2DAA3-C974-43BB-9289-F544FD8D52D9Q30472033-74BA536C-F9A4-4674-8375-81E65C839849Q30474256-BDF9A702-F2DB-429F-87FE-F0759E474C68Q30476810-2AFAD7FA-93FA-41C3-BD3F-E737BEF9856CQ30476813-7F5F02A8-1DD7-432E-A425-06230D81FB9DQ30481233-5646F92F-6194-4A10-BF8F-F0FF2AB08CDCQ30557426-24EEB955-56C1-4C0B-A6E9-6514FBC657F4Q30573050-7176EF7D-F50F-4B43-ACBD-ADCB0BFEE0CBQ33630685-DCCCAD4C-C410-4B64-BF9D-30122D7A464DQ33803160-7D142025-C409-45DF-91F9-E53F69E381F3Q33842202-79B8BA51-1373-4697-BC08-F01D28051041Q34058243-EF529A98-7702-4DA5-9CB2-A76DF563BF6DQ34154488-E86560E7-4265-4142-A8F9-11BD2032CA24Q34355688-3B3ADB8B-2306-4792-B9DD-82F92AC25BAEQ34379851-566AEB87-EC86-4F65-862D-C6C30D8A6AA2Q34423863-5A09A410-C42B-47E3-9887-8537418CA8B9Q34603149-04E3ACA4-20C8-40D1-82FB-65566519959FQ34764182-DF44EB05-FCB7-4CEB-AA1D-EF421D631574Q35683620-03E95BBD-4319-4B8E-B837-9A2C316FC29CQ35690513-B51595EA-3834-46EA-A042-814B3E06B208Q35861876-4D61C99A-058C-4012-A1F9-8D5C521CFB0DQ35875021-A4834760-9A98-41D7-BF0D-EE4C46074508Q36000841-DB144C46-C510-42A5-8B51-FA544593FD74Q36189837-5C8E1395-5DCC-4381-88C2-6164DD13F6A1
P2860
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
description
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Juni 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/06/02)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/06/02)
@nl
наукова стаття, опублікована в червні 2008
@uk
مقالة علمية (نشرت في 2-6-2008)
@ar
name
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@ast
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@en
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@nl
type
label
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@ast
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@en
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@nl
prefLabel
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@ast
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@en
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@nl
P2093
P2860
P3181
P356
P1476
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
@en
P2093
Chan-Juan Hao
Claire Xi Zhang
Hong-Ping Huang
Pan-Li Zuo
Xiao-Li Guo
Xiao-Wei Chen
P2860
P304
P3181
P356
10.1083/JCB.200711021
P407
P577
2008-06-02T00:00:00Z